文献速递中毒与环境急症重症综合管理与镇静镇痛

2011至2021年法国吸毒者致命中毒趋势:DRAMES登记分析

Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register.
PubMed 文献 · JAMA Netw Open · 2023-08-01
一句话结论法国DRAMES登记显示,2011–2021年4460例药物相关死亡中,美沙酮始终是首要单药或主导药物致死原因,可卡因合并使用死亡占比从30.8%升至57.8%。

该研究基于法国DRAMES国家登记,分析2011至2021年4460例药物相关死亡,数据收集涵盖人口学特征、法医尸检和毒理学报告。结果显示,在单药或主导药物致死中,美沙酮在整个研究期间居首(2011年44.7% vs 2021年35.9%),高于海洛因(2011年15.8% vs 2021年21.8%)。多药使用死亡从2011年23.2%升至2021年30.6%,阿片类仍涉及2021年85.9%的死亡,而与可卡因合并的死亡从2011年30.8%升至2021年57.8%。作者认为,阿片类单独或联合使用是药物相关死亡的主要贡献者,美沙酮是法国阿片类相关死亡的首要原因;大麻、新型精神活性物质和兴奋剂相关死亡增加,应密切监测。

要点

  • 在单药或主导药物致死中,美沙酮是2011至2021年整个研究期间的首要死因(2011年44.7%、2021年35.9%),均高于海洛因(2011年15.8%、2021年21.8%)。
  • 2021年约85.9%的药物相关死亡至少涉及一种阿片类,阿片类单独或联合使用是主要贡献者。
  • 与可卡因合并的药物死亡从2011年30.8%升至2021年57.8%,是主要趋势变化。
  • 多药使用死亡从2011年23.2%升至2021年30.6%;死亡人群平均年龄37.8岁(SD 10.5),男性死亡率最高(性别比4.4:1)。

适用人群与场景

  • 2011至2021年法国4460例药物相关死亡者,数据来自DRAMES国家登记,纳入所有由毒理学专家进行过分析的死亡案例。

研究设计与关键结果

  • 研究类型为病例系列,基于法国国家登记评估2011至2021年4460例药物相关死亡;数据分析时间为2012年1月1日至2022年12月31日。
  • 死亡者平均年龄37.8岁(SD 10.5),男性死亡率最高,性别比4.4:1。
  • 单药或主导药物致死中,美沙酮为整个研究期间首要死因:2011年44.7% vs 海洛因15.8%;2021年美沙酮35.9% vs 海洛因21.8%。
  • 2011至2021年,多数药物相关死亡从合法药物转向非法药物;丁丙诺啡、可卡因、海洛因、美沙酮及其他合法阿片类的变化有统计学意义。
  • 多药使用相关死亡从2011年23.2%升至2021年30.6%。
  • 2021年至少一种阿片类涉及约十分之九的病例(85.9%)。
  • 与可卡因合并的药物死亡从2011年不足三分之一(30.8%)升至2021年超过一半(57.8%)。

证据类型、等级与局限

  • 证据类型:基于国家登记的病例系列(DRAMES登记)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,阿片类单独或联合使用是药物相关死亡的主要贡献者;在法国,合法药物美沙酮是整个研究期间阿片类相关死亡的首要原因,高于海洛因。
  • 作者认为,与大麻、新型精神活性物质和兴奋剂(包括苯丙胺类兴奋剂和可卡因,尤其是联合使用)相关的死亡有所增加,应密切监测。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The DRAMES (Décès en Relation avec l'Abus de Médicaments Et de Substances) register is a database of drug-related deaths with the aim of identifying the psychoactive substances associated with and estimating the trends in these deaths. Our novel approach is based on the collection of data on all deaths for which toxicology experts have performed analyses.

OBJECTIVE: To describe drug-related deaths in France and report trends over an 11-year period.

DESIGN, SETTING, AND PARTICIPANTS: This case series used a national register to assess 4460 drug-related deaths that occurred from 2011 to 2021 in France. Data analyses were performed from January 1, 2012, to December 31, 2022.

MAIN OUTCOMES AND MEASURES: Demographic characteristics; medical and substance abuse history; forensic autopsy findings; and toxicology reports.

RESULTS: Among the 4460 deceased individuals (mean [SD] age, 37.8 [10.5] years), the mortality rate was highest among men (sex ratio, 4.4:1). Of the deaths involving a single or predominant drug, the legal substitution product, methadone, was the leading cause of death during the entire study period, ahead of heroin-44.7% and 35.9% for methadone vs 15.8% and 21.8% for heroin in 2011 and 2021, respectively. Between 2011 and 2021, most of the drug-related deaths shifted from licit to illicit drugs, and statistically significant variations were found for buprenorphine, cocaine, heroin, methadone, and other licit opioids. Deaths related to polydrug use increased from 23.2% in 2011 to 30.6% in 2021. In this context, opioids remained associated with most deaths, with at least 1 opioid being involved in approximately 9 of 10 cases (85.9%) in 2021. However, the main trend was the dramatic increase in drug combinations with cocaine, from less than one-third of cases in 2011 (30.8%) to more than half in 2021 (57.8%).

CONCLUSIONS AND RELEVANCE: This case series assessment of 4460 drug-related deaths found that opioids used alone or in combination were the main contributor to drug-related deaths, despite having a lower prevalence than other drugs. This finding is similar to that of other countries; however, in France licit methadone was the leading cause of opioid-related deaths (ahead of heroin) during the study period. Deaths associated with use of cannabis, new psychoactive substances, and stimulants (including amphetamine-type stimulants and cocaine, especially in combination) have increased and should be closely monitored.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Revol B, Willeman T, Manceau M, et al. Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register. JAMA Netw Open. 2023. PMID: 37647066. doi:10.1001/jamanetworkopen.2023.31398

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。